| 1.10 Data as of 1:35pm ET |  0.00 / 0.00%Today’s Change | 0.91 Today|||52-Week Range 2.99 | -21.99% Year-to-Date |
| Previous close | 1.10 |
| Today’s open | 1.09 |
| Day’s range | 1.05 - 1.13 |
| Volume | 303,790 |
| Average volume (3 months) | 756,049 |
| Market cap | $143.5M |
| Dividend yield | -- |
| Earnings growth (last year) | +30.77% |
| Earnings growth (this year) | +44.07% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | +11.12% |
| P/E ratio | NM |
| Price/Sales | 66.07 |
| Price/Book | 1.67 |
| Today’s change | Today’s % change | |
|---|---|---|
| --Medytox Solutions In... | 0.00 | 0.00% |
| BDSIBioDelivery Sciences... | +0.22 | +5.24% |
| INOInovio Pharmaceutica... | -0.01 | -1.41% |
| TROVTrovagene Inc | +0.38 | +5.99% |
| Next reporting date | August 1, 2013 |
| EPS forecast (this quarter) | -$0.07 |
| Annual revenue (last year) | $2.7M |
| Annual profit (last year) | -$68.9M |
| Net profit margin | -2,542.67% |
Sector Health Technology |
Industry Biotechnology |
President, Chief Executive Officer & Director John A. Scarlett, MD |
Chief Financial Officer, Treasurer, CAO & SVP Olivia K. Bloom, CPA |
Corporate headquarters Menlo Park, California |
.
